Targeted protein degradation is getting explored in its place system in cancer, whereby the pure protein degradation method is co-opted for therapeutic applications. Lately created novel molecules identified as proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. Just one ligand binds towards the ‘protein of https://www.directivepublications.org/journal-of-clinical-breast-cancer/